ORTHOPEDICS | Healio.com/Orthopedics n guest editorial M y father was a general practitioner who finished medical school around the end of the World War II. He said he was fortunate to have practiced through a great time in medicine, which coincided with the discovery and development of antibiotics. For the first time, doctors could aggressively treat conditions that they had previously only been able to diagnose. I finished a fellowship in spine surgery in 1980. I consider myself similarly fortunate because my career has encompassed an unprecedented change in the ability to safely and effectively treat all manner of spinal disorders, many of which were previously considered untreatable.
Up until the early 1980s, spinal instrumentation was limited. All we had were Harrington distraction and compression rods, Weiss springs, and Dwyer cables. These products were developed by innovative surgeons. As a fellow, I traveled to Mexico to see firsthand the work of Dr Eduardo Luque, who introduced segmental spinal instrumentation using sublaminar wires. Later, I visited Dr Harry Shufflebarger in Miami, Florida, to learn Cotrel Dubousset instrumentation. I then traveled to France to learn a pedicle screw technique from Dr Raymond Roy-Camille. From my own experiences, I would encourage young spine surgeons to try to find a way to travel and visit the masters and see their work firsthand. It may be Dr Jurgen Harms in Germany or Dr Se Il Suk in Korea or another rising star in another part of the world whom you want to observe. A globalization of new ideas has occurred in spine surgery.
The rapid development of new spine devices and techniques has occurred hand-in-hand with a proliferation of device manufacturing companies. In the 1980s, a small startup company called Danek grew rapidly to became Sofamor Danek, which was then was incorporated into Medtronic. The few companies involved in spinal instrumentation in the 1980s have expanded to more than 100 companies currently. Some of the new products and ideas that have been introduced over the past 3 decades include pedicle screws, interbody cages, biomechanical testing of devices, biologic alternatives to iliac crest bone graft, minimally invasive approaches, navigation, and now robotic screw insertion. These advances have been made possible through collaboration between innovative surgeons and the medical device industry. The United States has been a global leader in medical devices, one of the few major manufacturing industries that boasts being both a net trade surplus and a job creator. The sector employs 400,000 Americans directly and is indirectly responsible for almost 2 million more positions that supply and support the highly skilled workforce.
Throughout my career, I have worked closely with many companies on product development. This has included biomechanical testing, trial implantation in the laboratory at the medical school, and the introduction into clinical practice of approved implants. This has been a fascinating and intellectually rewarding adjunct to my career as a spine surgeon. I would recommend that young spine surgeons just beginning their careers who also have an interest in product development work persue these interests. I believe many of the best ideas come from the uncluttered minds of younger surgeons.
Because devices directly affect the health and welfare of human beings, the device industry is necessarily subject to intense public oversight and scrutiny. With the rapid increase in the use of devices, a similar increase seems to have occurred This has led to the Position Payments Sunshine Act.
As of August 2013, device makers will be required to report payments to physicians and these payments will be available on a public searchable Web site. One unfortunate result of the reports of these unethical practices is that many younger surgeons now steer clear from involvement with device makers. This is a pity and may have future negative consequences for the device industry, and ultimately for medical practice.
The device industry has addressed many of these problems through the AdvaMed Code of Ethics on Interactions with Health Care Professionals, 1 which clarifies appropriate activity between health care professionals and representatives of device companies that have agreed to the code. Not all device companies are signees. I would advise surgeons to read the code, but to summarize, surgeons who wish to work with the device industry should always strive to ensure that payment for work is in line with a fair and transparent quid pro quo (Latin for "this for that"), whether it is to cover time, teaching, travel, or royalties and patents. In particular, no payments should be made solely to ensure allegiance to a single company's products. I have made many lifelong friends in the implant industry, and all adhere to the highest ethical standards. However, the surgeon should remember that his responsibility is to his patients, whereas an engineer, salesman, or representative working for a company, although also responsible to the public, has to answer also to management and stockholders. It is a business, after all.
When Watson and Crick were beginning their work on DNA, they were told that all the great advances in medicine had already been made. I now hear the same for spinal implants and devices. I do not believe it; I think the rate of innovation has yet to plateau. This offers great opportunities for innovative young surgeons who have an interest in spinal device development to get involved with engineers and implant developers, but I caution them to read the AdvaMed Code of Ethics and remember that payment for this work should satisfy a strict quid pro quo.
